MedTrace Logo

A Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic Density

NCT03577262 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2020-02-20

No results posted yet for this study

Summary

Up to 20 subjects will receive an injection with \[11C\]-UCB-J followed by a PET scan on Days 1 and 28

Conditions

  • Healthy
  • Alzheimer Disease

Interventions

OTHER

[11C]-UCB-J

IV radioligand given prior to and during positron emission tomography (PET) scan

Sponsors & Collaborators

  • QPS Netherlands B.V.

    collaborator INDUSTRY

  • University Medical Center Groningen

    collaborator OTHER

  • Amsterdam UMC, location VUmc

    collaborator OTHER

  • Alkermes, Inc.

    lead INDUSTRY

Principal Investigators

  • Coordinating PI · University Medical Center Groningen

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-23
Primary Completion
2019-08-02
Completion
2019-08-02

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03577262 on ClinicalTrials.gov